Group 1 - The Shanghai Stock Exchange's Sci-Tech Innovation Board (STAR Market) has officially celebrated its 6th anniversary, emphasizing its focus on "hard technology" with over 588 listed companies, predominantly in integrated circuits, biomedicine, and high-end manufacturing, which account for over 60% of the total [2] - The integrated circuit sector on the STAR Market has 119 companies, representing a significant portion of A-share listed companies in the same category, covering the entire supply chain from chip design to packaging and testing [2] - The biomedicine sector includes 113 listed companies focusing on treatments for cancer, hepatitis B, hepatitis C, and AIDS, establishing itself as a major listing venue globally outside the US and Hong Kong [2] Group 2 - The top ten weighted stocks in the STAR Market index account for 22.3% of the index, with notable companies including Haiguang Information, Cambricon, and SMIC [4] - The Huaxia STAR Market ETF closely tracks the STAR Market Composite Index, which reflects the overall performance of eligible STAR Market listed companies, including dividend income [3][4] Group 3 - Investment sentiment in the technology sector remains cautious due to trade uncertainties, but there is a consensus that trade policies will not revert to earlier unfavorable conditions [3] - Artificial intelligence is identified as a key technological change, with expectations for market focus to shift back to infrastructure development and application realization in the latter half of the year [3] - There is an ongoing emphasis on domestic substitution processes within the technology supply chain, particularly in semiconductor design, equipment, and manufacturing [3]